ARJO-B Arjo AB (publ)

3.567USD36.24 SEK · STO-0.38%Mkt Cap: 971.57M USDP/E: 27.25

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions fo…

Institutional holders10 on file

Key Statistics

Company
Market Cap971.57M USD
Enterprise Value1.42B USD
Revenue (TTM)1.09B USD
Gross Profit461.14M USD
Net Income (TTM)32.88M USD
Revenue/Share4.02 USD
Last Price3.567 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees7.0K
CountrySE
SectorHealthcare
IndustryMedical Distribution
ISINSE0010468116
Valuation
P/E (Trailing)27.25
P/E (Forward)13.52
PEG—
EV/EBITDA9.39
EV/Revenue1.30
P/S0.89
P/B1.23
EPS (TTM)0.13 USD
EPS (Forward)0.26 USD
52W Range
2.32793% of range3.667
52W High3.667 USD
52W Low2.327 USD
Profitability
Gross Margin42.59%
Oper. Margin8.47%
EBITDA Margin13.79%
Profit Margin3.04%
ROE4.48%
ROA2.23%
ROIC4.98%
ROCE7.41%
Growth
Revenue Growth7.70%
Earnings Growth-28.40%
Cash Flow & Leverage
Operating CF141.25M USD
CapEx (TTM)69.69M USD
FCF Margin7.93%
FCF Yield8.93%
Net Debt445.98M USD
Net Debt/EBITDA2.96
Net Debt/FCF5.14
Balance Sheet
Debt/Equity0.72
Current Ratio1.19
Quick Ratio0.81
Book Value/Sh2.90 USD
Cash/Share0.31 USD
Dividends
Fwd Div Rate0.09 USD
Trail. Div Rate0.09 USD
Div. Yield2.61%
5Y Avg Yield2.15%
Payout Ratio71.43%
Ex-Div DateApr 23, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.425 USD
Upside (mean)-4.0%
Target Range2.953 USD – 3.937 USD
2.953-4.0% to mean3.937
# Analysts5
Ownership
Shares Out.254.15M
Float185.12M
Insiders25.56%
Institutions40.15%
Technical
SMA 503.028 (+17.8%)
SMA 2002.682 (+33.0%)
Beta0.66
S&P 52W Chg12.00%
Avg Vol (30d)490.56K
Avg Vol (10d)381.66K
Technical Indicators
RSI (14)74.4
MACD1.6936
MACD Signal1.8894
MACD Hist.-0.1958
BB Upper3.740 USD
BB Middle3.498 USD
BB Lower3.256 USD
BB Width13.85%
ATR (14)0.0783 USD
Vol Ratio (20d)0.45x

About Arjo (STO: ARJO-B)

›

Arjo (STO: ARJO-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 7,000 employees.

The shares were at 36.24 SEK on 19 November 2026, up 23.2% over 52 weeks. Its 52-week range is 23.64 SEK to 37.26 SEK: the price is 2.7% below the high and 53.3% above the low.

At a market capitalisation of 9.87B SEK, it trades at 27.2 times trailing earnings and 13.5 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 20.3, a premium of 34% for ARJO-B. It pays a dividend yielding 2.61% (it pays out 71% of its earnings), against a median of 1.38% among the dividend payers in that peer group.

Arjo reports return on equity of 4.5%, an operating margin of 8.5% and revenue up 7.7% year over year.

Its debt exceeds its cash by 4.53B SEK, a debt-to-equity ratio of 0.72. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 34.80 SEK is 4.0% below the current price. The next earnings report is expected on 28 January 2027.